Medical and Payment Policies

Note: Search functionality is limited to policy title

Sorry we didn't find anything that matched your search.

Draft Medical and Payment Policies
Identification of Microorganisms Using Nucleic Acid Probes - Effective 1/01/2024
Invasive Prenatal (Fetal) Diagnostic Testing - Effective 1/01/2024
Medical
Image Guided Minimally Invasive Spinal Decompression for Spinal Stenosis
Immune Cell Function Assay
Immune Cell Function Assay - Effective 1/01/2024
Implantable Bone Conduction and Bone Anchored Hearing Aids
In Vitro Chemoresistance and Chemosensitivity Assays
In Vitro Chemoresistance and Chemosensitivity Assays - Effective 1/01/2024
Ingestible Devices for the Treatment of Constipation
Ingestible pH and Pressure Capsule
Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Interferential Current Stimulation
Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)
Intra-Articular Hyaluronan Injection for Osteoarthritis
Intracellular Micronutrient Analysis
Intraocular Radiotherapy for Age-Related Macular Degeneration
Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Conditions
Intravitreal and Punctum Corticosteroid Implants
Islet Transplantation
Payment
Immunizations Adult and Pediatric
Inactive Provider Termination
Inpatient Admission
Intensive Behavioral Therapy (IBT) for Obesity
Intraocular Lens (IOL) Implant
Prior Authorization
Implantation of Intrastromal Corneal Ring Segments
Infertility Services
Infertility Services - Effective 1/01/2024
Intensity-Modulated Radiotherapy